tel: 86-731-84372980
2024 Public Welfare Project
Release time:
2024/05/24
source:
| Serial Number | Project Name | Application Conditions (Each project condition must be met simultaneously) | Aid Content | Quota | Remarks |
| 1 | Changsha Municipal Health and People's Livelihood Project—Comprehensive Prevention and Control of Inherited Rare Diseases | 1. At least one of the couple is diagnosed with an inherited rare disease, or the couple has given birth to a child with an inherited rare disease, or has a family history of genetic disease, or has had a miscarriage with chromosomal abnormalities, etc.;
2. One of the couple has Changsha household registration or the female has a Changsha residence permit (the residence permit is valid);
3. The female is not pregnant or is within 13 weeks of pregnancy; 4. The female is under 49 years old; 5. Provide marriage certificate, ID card, etc.; |
1. Provide free genetic testing; 2. Prenatal diagnosis subsidy of 2000 yuan; 3. One cycle of preimplantation genetic testing (PGT) fee of 5000 yuan; | Unlimited | Project Start and End Time: 2021.11.24-2024.11.23 |
| 2 | China Birth Defects Intervention and Relief Foundation—Birth Defects Relief Project (Functional Birth Defects Relief) | 1. Clinically diagnosed with inherited metabolic diseases, congenital structural malformations, or functional birth defects. Specific diseases covered are listed in the "List of Diseases Covered by the Birth Defects Relief Project"; 2. 18 years old (inclusive) or younger; 3. Heavy family burden, able to provide low-income guarantee, low-income certificate, or hardship certificate; or original copy of the family economic situation statement issued by the village (community) committee; 4. Receive diagnosis, treatment, surgery, and rehabilitation at the implementing institution; 5. The self-pay portion of medical expenses exceeds 3000 yuan (inclusive). |
1. For the self-pay portion greater than 3000 yuan (inclusive) but less than 5000 yuan, the medical expense subsidy is 3000 yuan; 2. For the self-pay portion greater than 5000 yuan (inclusive), the medical expense subsidy is 5000 yuan; |
Unlimited | 2025 |
| 3 | Clinical Research Project on Preimplantation Genetic Testing Combined with Prenatal Diagnosis for Mitochondrial Genetic Diseases | 1. Women carrying pathogenic mitochondrial DNA mutations who wish to use PGT for reproduction; | 1. Women who have been identified as carrying pathogenic mitochondrial DNA mutations; their families can receive free mitochondrial DNA mutation testing; 2. Couples who Enter PGT can have the mitochondrial DNA mutation-related embryo testing fee waived; 3. Couples who become pregnant through PGT can have the mitochondrial DNA mutation-related prenatal diagnosis fee waived during pregnancy; 4. All children born through PGT can receive free mitochondrial DNA mutation testing. (Total reduction of approximately 30,000 yuan/family) |
Unlimited | 2025 |
| 4 | Preimplantation Chromosomal Structural Abnormality Detection Project - Clinical Trial | If you meet all three of the following conditions, you can participate in this trial: 1. Patients with chromosomal structural abnormalities (including reciprocal translocations and Robertsonian translocations) in one of the couple, who wish to undergo in vitro fertilization; 2. Have a family peripheral blood sample with a qualified karyotype (the family meets any of the following conditions) A. The subject couple; B. The subject couple and the father or mother of the balanced translocation patient in the couple; C. The subject couple and their offspring. 3. The embryo samples to be tested are trophectoderm biopsy samples. Note: The above are the inclusion criteria. The final decision on whether or not to be included will be made by the doctor. Participants will receive a trial subsidy. |
A subsidy of 1000 yuan per embryo for testing (unlimited number of embryos, unlimited number of cycles) | 100 | January 2025 |
| 5 | Preimplantation Genetic Testing for Aneuploidy - Clinical Trial | Meet all of the following inclusion criteria: 1. The couple meets at least one of the following indications: ① Women aged 35 and above undergoing in-vitro fertilization; ② Couples where one or both partners have chromosomal abnormalities; ③ Three or more IVF implantation failures; ④ Three or more miscarriages; ⑤ Couples who have given birth to a child with chromosomal abnormalities. 2. Trophectoderm biopsy samples from embryos that have developed to the blastocyst stage. Note: The above inclusion criteria are basic requirements. The final decision on inclusion will be made by the research physician based on all inclusion and exclusion criteria. Participants will receive a trial subsidy. |
A subsidy of 1000 yuan per embryo for testing (unlimited number of embryos, unlimited number of cycles) | 250 | October 2024 |
Previous
More Expert Recommendations